Antheia

Menlo Park, United States

Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.

$24.0M raised

Jan 2026

Series C

Biotechnology Health Care Manufacturing Pharmaceutical

Top Investors

National Science FoundationSilicon Valley BankCivilization VenturesAmerica‚Äôs Frontier FundViking Global Investors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Antheia

How much funding has Antheia raised?

Antheia has raised $24.0M in total funding. The most recent round was Series C. The last funding was announced in January 2026.

Who are Antheia's investors?

Antheia's investors include National Science Foundation, Silicon Valley Bank, Civilization Ventures, America‚Äôs Frontier Fund, Viking Global Investors.

Where is Antheia headquartered?

Antheia is headquartered in Menlo Park, United States.

What does Antheia do?

Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.

What stage is Antheia at?

Antheia is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 27, 2026.

MLA

"Antheia — Funding & Investors." VCBacked, January 27, 2026, https://www.vcbacked.co/company/antheia. Accessed June 3, 2026.

APA

VCBacked. (2026). Antheia — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/antheia

Wikipedia (cite web)

{{cite web |title=Antheia — Funding & Investors |url=https://www.vcbacked.co/company/antheia |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 27, 2026.

Similar Companies in Biotechnology